Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Xortx Therapeutics (TSE:XRTX)
:XRTX
Holding TSE:XRTX?
Track your performance easily
XRTX Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$1.28 - C$9.35
Previous CloseN/A
Volume514.00
Average Volume (3M)3.66K
Market Cap
C$5.36M
Enterprise ValueC$3.22M
Total Cash (Recent Filing)$185.78K
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.77
Next Earnings
Apr 30, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding3,481,375
10 Day Avg. Volume9,174
30 Day Avg. Volume3,662
Standard Deviation0.31
R-Squared0.00057
Alpha-0.00069
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.30
P/FCF Ratio0.00
Enterprise Value/Market Cap0.60
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-5.18
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
XORTX Therapeutics Inc News
PremiumCompany Announcements
XORTX Therapeutics Announces Auditor Transition
PremiumCompany Announcements
XORTX Therapeutics Expands Pipeline with Late-Stage Gout Program
PremiumCompany Announcements
XORTX Therapeutics Welcomes New CFO Dr. Bumby
PremiumCompany Announcements
XORTX Therapeutics Unveils New Kidney Disease Discoveries
Options Prices
Currently, No data available
---
Ownership Overview
XRTX FAQ
What was Xortx Therapeutics’s price range in the past 12 months?
Xortx Therapeutics lowest stock price was C$1.28 and its highest was C$9.35 in the past 12 months.
What is Xortx Therapeutics’s market cap?
Xortx Therapeutics’s market cap is C$5.36M.
When is Xortx Therapeutics’s upcoming earnings report date?
Xortx Therapeutics’s upcoming earnings report date is Apr 30, 2025 which is in 98 days.
How were Xortx Therapeutics’s earnings last quarter?
Xortx Therapeutics released its earnings results on Nov 15, 2024. The company reported -C$0.276 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.276.
Is Xortx Therapeutics overvalued?
According to Wall Street analysts Xortx Therapeutics’s price is currently Overvalued.
Does Xortx Therapeutics pay dividends?
Xortx Therapeutics does not currently pay dividends.
What is Xortx Therapeutics’s EPS estimate?
Xortx Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Xortx Therapeutics have?
Xortx Therapeutics has 3,481,375 shares outstanding.
What happened to Xortx Therapeutics’s price movement after its last earnings report?
Xortx Therapeutics reported an EPS of -C$0.276 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Xortx Therapeutics?
Currently, no hedge funds are holding shares in TSE:XRTX
---
Company Description
Xortx Therapeutics
XORTX Therapeutics Inc is focused on developing drug therapies for orphan disease like polycystic kidney disease, and treatment of health consequences caused by chronic high serum uric acid which include cardiovascular disease and diabetes.
---
Technical Analysis
---